Clin2
NCT07525219Likely a fitRecruiting

Pain Relief During Stereotactic Head Frame Placement

Analgesic Efficacy

Treatments studied

Part of Pain clinical trials.

This study compares a new pain medication called suzetrigine with acetaminophen (Tylenol) for patients who need a stereotactic head frame placed as part of their scheduled medical procedure. The frame holds your head still during brain imaging or treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
80 people
Ages
21 years and older
Study type
Interventional

Who can take part

  • You must have a scheduled medical procedure that requires placing a stereotactic head frame
  • The procedure must be a standard of care treatment (not experimental)
  • You must be willing to receive either suzetrigine or acetaminophen for pain management
  • You must be able to participate in the study during your procedure

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07463430Enrolling by invitation· Phase 4
Suzetrigine for pain after non-mastectomy breast surgery

This trial tests a new pain medication, suzetrigine, for people having breast surgery (not mastectomy) who are expected to have moderate pain. It checks if this drug works well compared to standard options.

San Diego, California
NCT07539623Recruiting· Phase 3
Pain relief with suzetrigine after heart or weight-loss surgery

This study tests whether suzetrigine, a new pain medication, can reduce the need for opioids (strong painkillers) after cardiac or bariatric surgery. The goal is to help patients manage pain with fewer opioid-related side effects.

New York, New York
NCT07357376Not yet recruiting· Phase 3
Study of suzetrigine for pain after knee replacement surgery

This study tests a new pain medicine called suzetrigine for people having a first-time total knee replacement. The goal is to see if it helps control pain after surgery.

NCT07548385Recruiting· Phase 3
New pain medicine for after knee replacement surgery

This study tests a new medication called suzetrigine to help manage pain after knee replacement surgery. The goal is to see if it reduces pain and discomfort better than current treatments.

New York, New York
NCT07624526Not yet recruiting· Phase 4
Suzetrigine to Reduce Pain and Opioid Use After Knee Surgery

This study tests whether a new pain medication called suzetrigine, when combined with other pain-management strategies, can reduce pain and the need for opioids after total knee replacement surgery. The goal is to help patients recover comfortably while using fewer opioids.

Atlanta, Georgia
NCT07226700Recruiting· Phase 3
Suzetrigine for pain after hip replacement surgery

This study tests an investigational pain medicine called suzetrigine to see how well it controls pain after total hip replacement surgery. It is for adults 18–80 who are having a first-time hip replacement and can receive spinal anesthesia.

New York, New York

Hear when a new Analgesic Efficacy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.